Skip to main content
padlock icon - secure page this page is secure

Retinopathy of Prematurity: Pathogenesis and Current Treatment Options

Buy Article:

$17.00 + tax (Refund Policy)

Retinopathy of prematurity (ROP) is a vasoproliferative retinal disorder that continues to be the major cause of preventable childhood blindness worldwide. Its incidence is inversely proportional to gestational age and birth weight. Approximately 65 percent of neonates with <1,250 g birth weight and 80 percent of those with 1,000 g birth weight will develop some degree of ROP. ROP can cause mild retinal disease without major visual defects or can adversely progress to retinal detachment and blindness through aggressive vascular proliferation. The purpose of this article is to raise awareness about the history of ROP, pathogenesis, normal retinal vascular development, international classification of ROP, and risk factors. Conventional ROP treatment and the promising antivascular endothelial growth factor monotherapy will also be explored.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics


Document Type: Research Article

Publication date: September 1, 2015

More about this publication?
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more